See more : Fission Uranium Corp. (FCUUF) Income Statement Analysis – Financial Results
Complete financial analysis of Creative Medical Technology Holdings, Inc. (CELZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Creative Medical Technology Holdings, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Shang Hai Ya Tong Co.,Ltd. (600692.SS) Income Statement Analysis – Financial Results
- Cenovus Energy Inc. (CVE) Income Statement Analysis – Financial Results
- Future Bright Mining Holdings Limited (2212.HK) Income Statement Analysis – Financial Results
- ANTA Sports Products Limited (ANPDF) Income Statement Analysis – Financial Results
- Country Garden Services Holdings Company Limited (6098.HK) Income Statement Analysis – Financial Results
Creative Medical Technology Holdings, Inc. (CELZ)
About Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9.00K | 88.60K | 87.75K | 164.50K | 165.50K | 124.40K | 4.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 3.60K | 28.49K | 47.95K | 50.60K | 45.50K | 70.38K | 8.00K | 766.07K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 5.40K | 60.11K | 39.81K | 113.90K | 120.00K | 54.03K | -3.20K | -766.07K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 60.00% | 67.84% | 45.36% | 69.24% | 72.51% | 43.43% | -66.67% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 1.97M | 6.27M | 109.18K | 0.00 | 0.00 | 96.62K | 260.09K | 85.33K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 1.22M | 1.05M | 898.53K | 664.98K | 20.83K | 19.43K | 20.12K | 20.10K | 0.00 | 14.29K | 30.55K | 53.49K | 13.62K | 1.43K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.56M | 3.94M | 2.96M | 1.16M | 1.22M | 1.05M | 898.53K | 664.98K | 20.83K | 19.43K | 20.12K | 20.10K | 19.83K | 14.29K | 30.55K | 53.49K | 13.62K | 1.43K |
| Other Expenses | 94.58K | 92.08K | 92.08K | 66.79K | 26.95K | 21.14K | 0.00 | 9.36K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 5.63M | 10.30M | 3.17M | 1.23M | 1.25M | 1.17M | 1.17M | 759.67K | 20.83K | 19.43K | 20.12K | 20.10K | 19.83K | 14.29K | 30.55K | 53.49K | 13.62K | 1.43K |
| Cost & Expenses | 5.63M | 10.33M | 3.21M | 1.28M | 1.30M | 1.24M | 1.18M | 759.67K | 20.83K | 19.43K | 20.12K | 20.10K | 19.83K | 14.29K | 30.55K | 53.49K | 13.62K | 1.43K |
| Interest Income | 333.56K | 100.33K | 4.28M | 1.23M | 1.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 469.00 | 2.33K | 1.95K |
| Interest Expense | 0.00 | 0.00 | 4.28M | 1.23M | 1.90M | 1.36M | 377.59K | 6.40K | 9.93K | 8.59K | 7.16K | 5.49K | 4.23K | 2.97K | 1.06K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 94.58K | 92.08K | 92.08K | 66.79K | 26.95K | 21.14K | 15.99K | 9.36K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -5.53M | -10.15M | -3.03M | -1.05M | -1.10M | -1.09M | -1.16M | -750.32K | -20.83K | -19.43K | -20.12K | -20.10K | -19.83K | -14.29K | -30.55K | -53.49K | -13.62K | -1.43K |
| EBITDA Ratio | -61,394.98% | -11,345.33% | -3,457.24% | -637.11% | -666.60% | -878.68% | -24,204.40% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -5.62M | -10.24M | -3.13M | -1.11M | -1.13M | -1.11M | -1.18M | -766.07K | -20.83K | -19.43K | -20.12K | -20.10K | -19.83K | -14.29K | -30.55K | -53.49K | -13.62K | -1.43K |
| Operating Income Ratio | -62,445.91% | -11,562.50% | -3,562.17% | -677.71% | -682.88% | -895.68% | -24,537.63% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 333.56K | 100.33K | 22.34M | -35.21M | -7.35M | -12.54M | -1.48M | -6.40K | -9.93K | -8.59K | -7.16K | -5.49K | -4.23K | -2.97K | -1.06K | 2.22K | 2.33K | 1.95K |
| Income Before Tax | -5.29M | -10.14M | 19.21M | -36.33M | -8.48M | -13.66M | -2.66M | -766.07K | -30.76K | -28.01K | -27.28K | -25.59K | -24.06K | -17.26K | -31.61K | -51.27K | -11.29K | 523.00 |
| Income Before Tax Ratio | -58,739.71% | -11,449.26% | 21,892.75% | -22,082.21% | -5,126.09% | -10,977.21% | -55,398.08% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -100.33K | 4.28M | 1.23M | 1.90M | -11.18M | 377.59K | 12.80K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.36K | -661.00 | 162.00 |
| Net Income | -5.29M | -10.04M | 14.93M | -37.55M | -10.38M | -13.66M | -2.66M | -766.07K | -30.76K | -28.01K | -27.28K | -25.59K | -24.06K | -17.26K | -31.61K | -52.64K | -9.54K | 1.37K |
| Net Income Ratio | -58,739.71% | -11,336.02% | 17,017.27% | -22,829.68% | -6,271.42% | -10,977.21% | -55,398.08% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | -3.76 | -9.19 | 57.32 | -648.10 | -5.02K | -11.35K | -17.38K | -5.47K | -1.28K | -1.17K | -1.14K | -1.07K | -1.00K | -719.00 | -1.32K | -2.19K | -397.67 | 57.17 |
| EPS Diluted | -3.76 | -9.19 | 45.97 | -648.10 | -5.02K | -11.35K | -17.38K | -5.47K | -1.28K | -1.17K | -1.14K | -1.07K | -1.00K | -719.00 | -1.32K | -2.19K | -397.67 | 57.17 |
| Weighted Avg Shares Out | 1.41M | 1.09M | 260.51K | 57.95K | 2.07K | 1.20K | 153.00 | 140.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 |
| Weighted Avg Shares Out (Dil) | 1.41M | 1.09M | 324.86K | 57.95K | 2.07K | 1.20K | 153.00 | 140.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 | 24.00 |
Best Reddit Penny Stocks To Buy Now? 5 Trending Stocks To Watch Today
What are the best penny stocks to buy today? The post Best Reddit Penny Stocks To Buy Now?
8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI, WAVE
We're diving into the top penny stocks to watch today as several names in the space see major movement on Monday alongside heavy trading. The post 8 Top Penny Stocks to Watch Today: EVGRF, PTE, BLCT, GNPX, AFI, CELZ, AUVI,...
CELZ Stock: 5 Things to Know About Trending Penny Stock Creative Medical Technology
Creative Medical Technology (CELZ) stock is taking off on Monday despite a lack of news from the commercial-stage biotechnology company. The post CELZ Stock: 5 Things to Know About Trending Penny Stock Creative Medical Technology appeared first on InvestorPlace.
Best Penny Stocks to Buy Today? 3 For Your Watchlist in January
Are these penny stocks on your watchlist right now? The post Best Penny Stocks to Buy Today?
Creative Medical Technology Stock (CELZ): Why The Price Surged Today
The stock price of Creative Medical Technology Holdings Inc (NASDAQ: CELZ) increased by over 50% pre-market today. This is why it happened.
Low Float Penny Stocks To Buy For Under $5 After RELI Surges 250%
Low float penny stocks to add to your watch list this week The post Low Float Penny Stocks To Buy For Under $5 After RELI Surges 250% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Source: https://incomestatements.info
Category: Stock Reports